| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 29/03/2019 | 08:00 | UK Regulatory | AIM Cancellation - Akers Biosciences, Inc. | LSE:AKR | Akers Bio |
| 06/03/2019 | 11:23 | Alliance News |  Shareholders Approve Akers Biosciences Shares Delisting At March-End (ALLISS) | LSE:AKR | Akers Bio |
| 06/03/2019 | 08:00 | UK Regulatory | Akers Biosciences, Inc. Result of Special Meeting of Shareholders | LSE:AKR | Akers Bio |
| 06/02/2019 | 10:00 | UK Regulatory | Akers Biosciences, Inc. Holding in Company | LSE:AKR | Akers Bio |
| 06/02/2019 | 08:01 | UK Regulatory | Akers Biosciences, Inc. Form DEFA14A Filing - Additional Proxy Materials | LSE:AKR | Akers Bio |
| 06/02/2019 | 08:00 | UK Regulatory | Akers Biosciences, Inc. Notice of Special Meeting of Shareholders | LSE:AKR | Akers Bio |
| 05/02/2019 | 14:00 | UK Regulatory | Akers Biosciences, Inc. Further Re. Directorate Change | LSE:AKR | Akers Bio |
| 28/01/2019 | 08:00 | UK Regulatory | Akers Biosciences, Inc. Form PRE 14A Filing | LSE:AKR | Akers Bio |
| 28/12/2018 | 16:45 | UK Regulatory | Akers Biosciences, Inc. Director/PDMR Shareholding | LSE:AKR | Akers Bio |
| 19/12/2018 | 17:59 | Alliance News | Akers Biosciences Plans To Exit AIM Market By Next March (ALLISS) | LSE:AKR | Akers Bio |
| 19/12/2018 | 17:45 | UK Regulatory | Akers Biosciences, Inc. Intention to Delist from AIM | LSE:AKR | Akers Bio |
| 18/12/2018 | 19:00 | UK Regulatory | Akers Biosciences, Inc. Issue of Equity | LSE:AKR | Akers Bio |
| 10/12/2018 | 08:00 | UK Regulatory | Akers Biosciences, Inc. Result of AGM & Form 8-K Filing | LSE:AKR | Akers Bio |
| 26/11/2018 | 15:00 | UK Regulatory | Akers Biosciences, Inc. Further Re. Notice of AGM | LSE:AKR | Akers Bio |
| 19/11/2018 | 15:25 | Alliance News | Akers Biosciences Evaluates Opportunities In Cannabis Sector | LSE:AKR | Akers Bio |
| 19/11/2018 | 15:00 | UK Regulatory | Akers Biosciences, Inc. Further Re. Strategic Update | LSE:AKR | Akers Bio |
| 19/11/2018 | 14:56 | Alliance News | Akers Biosciences Restored To Trading On AIM Following Stock Split (ALLISS) | LSE:AKR | Akers Bio |
| 19/11/2018 | 08:30 | UK Regulatory | AIM Restoration - Akers Biosciences, Inc | LSE:AKR | Akers Bio |
| 16/11/2018 | 17:00 | UK Regulatory | Akers Biosciences, Inc. Reverse Stock Split Update | LSE:AKR | Akers Bio |
| 15/11/2018 | 15:00 | Alliance News | Akers Biosciences Third-Quarter Loss Widens On Admin And Legal Costs | LSE:AKR | Akers Bio |
| 15/11/2018 | 08:01 | UK Regulatory | Akers Biosciences, Inc. 3rd Quarter 2018 Results | LSE:AKR | Akers Bio |
| 15/11/2018 | 08:01 | UK Regulatory | Akers Biosciences, Inc. Notice of AGM | LSE:AKR | Akers Bio |
| 12/11/2018 | 08:00 | UK Regulatory | Akers Biosciences, Inc. Form 8-K Filing | LSE:AKR | Akers Bio |
| 08/11/2018 | 12:59 | Alliance News | Akers Biosciences Shares Suspended Following Reverse Stock Split (ALLISS) | LSE:AKR | Akers Bio |
| 08/11/2018 | 08:30 | UK Regulatory | AIM Suspension - Akers Biosciences, Inc. | LSE:AKR | Akers Bio |
| 08/11/2018 | 08:00 | UK Regulatory | Akers Biosciences, Inc. Temporary Suspension of Share Trading on LSE | LSE:AKR | Akers Bio |
| 07/11/2018 | 16:28 | Alliance News | Akers Biosciences Evaluates Options, To Undertake Reverse Stock Split (ALLISS) | LSE:AKR | Akers Bio |
| 07/11/2018 | 16:02 | Alliance News | *Akers Biosciences Undertakes 1-For-8 Reverse Stock Split (ALLISS) | LSE:AKR | Akers Bio |
| 07/11/2018 | 16:01 | Alliance News | *Akers Biosciences To Evaluate Strategic Alternatives To Maximize Shareholder Value | LSE:AKR | Akers Bio |
| 07/11/2018 | 15:50 | UK Regulatory | Akers Biosciences, Inc. Strategic Update & Reverse Stock Split | LSE:AKR | Akers Bio |